The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 Trial
美国大B细胞淋巴瘤患者二线治疗中Axicabtagene Ciloleucel的成本效益:ZUMA-7试验的经济评价
期刊:Transplantation and Cellular Therapy
影响因子:4.4
doi:10.1016/j.jtct.2022.08.010
Perales, Miguel-Angel; Kuruvilla, John; Snider, Julia Thornton; Vadgama, Sachin; Blissett, Rob; El-Moustaid, Fadoua; Smith, Nathaniel J; Patel, Anik R; Johnston, Patrick B